01 Industry overview
The remote patient monitoring industry at a glance
The global remote patient monitoring system market was valued at $26.0 billion in 2025 and is estimated at $30.9 billion in 2026, reflecting rapid adoption of connected devices, telehealth and home-based care.
- $30.9B[5]
- 2026 market estimate
- 20.0%[5]
- 2026–2033 CAGR
- 40.4%[5]
- North America share, 2025
- 58.89%[16]
- Hospital software share, 2025
- Market size
- The global remote patient monitoring system market was valued at $26.0 billion in 2025 and is estimated to reach $30.9 billion in 2026. A separate software-and-services estimate placed the market at $8.47 billion in 2023, illustrating how market totals vary by scope and inclusion of devices.[5]
- Forecast & CAGR
- Grand View Research projects the system market to reach $110.7 billion by 2033, at a 20.0% CAGR from 2026 to 2033. Mordor Intelligence forecasts the software segment to grow from $20.73 billion in 2026 to $84.17 billion in 2031, representing a 32.35% CAGR.[5][16]
- Market share & regions
- North America accounted for 40.4% of global remote patient monitoring system revenue in 2025. Asia-Pacific is identified as the fastest-growing region for remote patient monitoring software during 2026–2031.[5][16]
- Segmentation
- Special monitors represented 89.7% of system revenue by product in 2025, while diabetes represented 13.7% by application. In software, hospitals and health systems held 58.89% of revenue in 2025; major use cases include cardiovascular disease, diabetes, cancer and sleep disorders.[5][16]
- Key players & concentration
- The remote patient monitoring software market is assessed as having medium concentration. Major industry participants include device, software and care-delivery companies such as Medtronic, Philips, iRhythm, BioTelemetry, Masimo, Abbott and ResMed, although a single comparable global market-share table was not publicly disclosed.[16][17]
- Pricing
- Medicare RPM reimbursement is structured around 3 components: patient education and device setup, device supply and data transmission, and treatment management. Eligibility generally requires an internet-connected medical device transmitting data at least 2 days every 30 days; CMS pays the components separately rather than using one universal RPM price.[15][18]
- Trends, drivers & challenges
- Growth is being driven by chronic-disease prevalence, telehealth adoption, connected wearables, home healthcare and demand for continuous data. Key challenges include clinical workload, device connectivity, data integration, reimbursement uncertainty and the need to demonstrate reliable outcomes; CMS proposed changes to remote-monitoring policy for 2027.[5][14][19]
- Consumer behavior & competition
- Remote monitoring is shifting from episodic device sales toward recurring software, data and care-management services. HealthSnap reported more than 80,000 active patient programs across 200 health systems and physician organizations in 2026, while Cadence raised $100 million in Series C funding to expand AI-enabled chronic-care monitoring.[9][19]
- M&A
- M&A activity continued in 2026, including iRhythm’s completed $237.5 million acquisition of VitalConnect in October 2026. The transaction expanded iRhythm’s cardiac monitoring platform across ambulatory, inpatient and hospital-to-home care.[9][20]
- Regulation
- Medicare has covered remote patient monitoring since 2018. Current CMS guidance requires an FDA-defined medical device that digitally uploads physiologic data, at least 2 transmitted readings every 30 days, patient education and setup, device supply, and clinical treatment management.[15][21]
- Latest news
- In October 2026, AT&T and Smart Meter expanded their connected-health collaboration to improve connectivity for remote monitoring devices. In June 2026, Medtronic announced a U.S. distribution agreement for Corsano’s FDA-cleared multi-parameter wearable for hospital and hospital-to-home use.[22][17]
02 Ranking
Top 10 Companies in the Remote Patient Monitoring Industry
The leading companies in the remote patient monitoring industry, ranked on market impact, performance, momentum, innovation and brand popularity.
Updated November 20, 2026 · Next review December 20, 2026
Dexcom stands out for continuous glucose monitoring in remote diabetes management because it reports an operating margin of 19.6%, while Medtronic focuses on implantable and connected patient monitoring since its R&D is 7.9% of revenue.
Ranked by Overall score · How we score ↓
Editor's top 3 picks
Where to start, by need.
#1 Overall · Leader in remote vital-sign devices
Dexcom
US
Ranked #1 · 9.3 · Remote vital-sign devices
Why we picked it: Dexcom manufactures continuous glucose monitoring systems for ongoing remote diabetes management, with an operating margin of 19.6%.
#2 overall
Medtronic
IE
Ranked #2 · 9.2 · Remote vital-sign devices
Why we picked it: Medtronic operates in implantable and connected patient monitoring, with operating margin of 17.8% and R&D at 7.9% of revenue.
#3 overall
Boston Scientific
US
Ranked #3 · 9.1 · Remote vital-sign devices
Why we picked it: Boston Scientific is listed among major remote patient monitoring companies, reporting an operating margin of 18% and R&D at 10.2%.
Pick 1 is the #1 company overall. No other segment places in the top 5, so picks 2 and 3 follow rank.
Full ranking
| # | Company | Overall ↓ | Impact | Performance | Momentum | Innovation | Company snapshot |
|---|---|---|---|---|---|---|---|
| 1 | Dexcom Remote vital-sign devices · US | 9.3 | 9.3 | 9.6 | 9.5 | 9.0 | |
Company snapshot · Dexcom · Data as of November 20, 2026 Dexcom manufactures continuous glucose monitoring systems used for ongoing remote diabetes management.[23]
| |||||||
| 2 | Medtronic Remote vital-sign devices · IE | 9.2 | 9.8 | 8.8 | 9.3 | 7.7 | |
Company snapshot · Medtronic · Data as of November 20, 2026 Medtronic is identified as a major global remote patient monitoring market participant.[24]
| |||||||
| 3 | Boston Scientific Remote vital-sign devices · US | 9.1 | 8.5 | 9.9 | 9.9 | 8.9 | |
Company snapshot · Boston Scientific · Data as of November 20, 2026 Boston Scientific is listed among major companies operating in remote patient monitoring.[24]
| |||||||
| 4 | ResMed Remote vital-sign devices · US | 8.9 | 9.4 | 8.9 | 9.3 | 7.9 | |
Company snapshot · ResMed · Data as of November 20, 2026 ResMed connects out-of-hospital devices and software to support personalized care at home.[25]
| |||||||
| 5 | Withings Remote vital-sign devices · FR | 8.9 | 7.7 | 9.6 | 9.3 | 9.2 | |
Company snapshot · Withings · Data as of November 20, 2026 Withings designs connected scales, watches and monitors used in remote health tracking.[23]
| |||||||
| 6 | Siemens Healthineers Hospital and remote monitoring systems · DE | 8.9 | 8.5 | 8.5 | 8.9 | 9.2 | |
Company snapshot · Siemens Healthineers · Data as of November 20, 2026 Siemens is identified among major companies operating in remote patient monitoring.[24]
| |||||||
| 7 | VitalConnect Wearable biosensor monitoring · US | 8.6 | 7.7 | 9.1 | 9.3 | 9.2 | |
Company snapshot · VitalConnect · Data as of November 20, 2026 VitalConnect provides wireless wearable biosensors for patient monitoring in homes and hospitals.[23]
| |||||||
| 8 | Omron Healthcare Connected blood-pressure monitoring · JP | 8.4 | 8.5 | 8.0 | 8.9 | 7.7 | |
Company snapshot · Omron Healthcare · Data as of November 20, 2026 Omron Healthcare supplies connected blood-pressure devices for home monitoring.[24]
| |||||||
| 9 | BioIntelliSense Wearable vital-sign monitoring · US | 8.2 | 7.7 | 8.6 | 8.9 | 8.5 | |
Company snapshot · BioIntelliSense · Data as of November 20, 2026 BioIntelliSense provides wearable sensors and remote monitoring solutions for clinical care.[26]
| |||||||
| 10 | AliveCor Mobile ECG and cardiac monitoring · US | 8.1 | 7.7 | 8.6 | 7.8 | 8.5 | |
Company snapshot · AliveCor · Data as of November 20, 2026 AliveCor develops ECG hardware and software for remote heart-rhythm monitoring.[27]
| |||||||
How we score
- Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
- Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
- Momentum (20%): growth trajectory and future potential.
- Innovation (15%): R&D intensity and how technologically advanced the company is.
Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.
Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.
Cadence Recalculated when new figures are published; next review December 20, 2026.
Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.
Cite this ranking
APA
Kevin O'Brien. (2026, February 13). Top 10 companies in the remote patient monitoring industry. In Remote Patient Monitoring Industry Statistics. Gitnux. https://gitnux.org/remote-patient-monitoring-industry-statistics/#top-companies
Traditional Medicare beneficiaries with at least one remote patient monitoring claim (United States)
Traditional Medicare beneficiaries with at least one remote patient monitoring claim grew from 44K in 2019 to 451K in 2023.
03 Trends & forecasts
Top 10 Remote Patient Monitoring Industry Trends & Forecasts 2027
What is changing in the remote patient monitoring industry, with the evidence behind each trend and a forecast for 2027.
Forecasts were generated by an AI model from the cited evidence. They are estimates, not guarantees.
01Global market growth remains rapid
High confidenceGrand View Research estimates the global remote patient monitoring system market at $26.0 billion in 2025 and $30.9 billion in 2026, with a projected 20.0% CAGR through 2033 and a value of $110.7 billion in 2033.[5]
Forecast 2027: The market should exceed $37 billion in 2027 if the 2026–2033 growth path broadly holds. Growth will remain concentrated in connected devices, monitoring software and recurring clinical services.
02Chronic-care demand keeps expanding
High confidenceCadence reported in June 2026 that its AI-supported chronic-care model was treating more than 100,000 active patients across over 20 health-system partnerships. Its published deployments reported a 27% reduction in hospital admissions and a $1,302 annual reduction in per-patient total cost of care.[28]
Forecast 2027: In 2027, chronic disease management will remain the largest demand pool for RPM, especially hypertension, diabetes, heart failure and respiratory disease. Providers will increasingly evaluate programs by avoided utilization and total-cost impact rather than enrollment alone.
03Home-based care gains clinical scope
High confidenceiRhythm completed its $237.5 million cash acquisition of VitalConnect in October 2026, explicitly expanding its monitoring platform across ambulatory, inpatient and hospital-to-home care. The transaction broadens RPM beyond conventional outpatient monitoring into transitions of care and hospital-at-home workflows.[29]
Forecast 2027: By 2027, more programs will combine inpatient telemetry, discharge monitoring and longitudinal home care on one platform. This will increase demand for devices that can move with patients across care settings and for software that supports handoffs between hospital and community teams.
04Software captures more recurring value
Medium confidenceMarket estimates increasingly separate device-inclusive system revenue from software-and-services revenue; one estimate put software and services at $8.47 billion in 2023, while Mordor Intelligence projects RPM software growth from $20.73 billion in 2026 to $84.17 billion in 2031. The difference in scope highlights the category's shift toward subscriptions, analytics and care-management revenue.[5][16]
Forecast 2027: In 2027, vendors will increasingly price RPM as a recurring platform and clinical-service bundle rather than a one-time device sale. Software, workflow integration and managed monitoring should account for a growing share of customer budgets.
05AI reduces monitoring labor intensity
High confidenceCadence raised $100 million in Series C funding in June 2026 to scale AI-supported chronic-care operations. The company reported a median response time of 3.5 minutes for incoming vital-sign alerts, with 55% resolved appropriately without human adjustment.[28]
Forecast 2027: In 2027, AI will be deployed mainly for triage, alert prioritization, patient outreach and documentation under clinician supervision. Adoption will favor systems that demonstrate lower alert burden and faster response without weakening clinical accountability.
06Multi-parameter wearables broaden use cases
Medium confidenceThe VitalConnect acquisition gives iRhythm access to wearable biosensor and multi-vital monitoring capabilities, while Medtronic announced a 2026 U.S. distribution agreement for Corsano's FDA-cleared multi-parameter wearable for hospital and hospital-to-home use. These developments show supply moving from single-purpose measurements toward broader physiologic monitoring.[29][17]
Forecast 2027: In 2027, multi-parameter patches and wearables will gain share in cardiac monitoring, post-acute care and hospital-at-home programs. Buyers will favor devices that reduce the number of separate sensors while maintaining clinical-grade data quality.
07Cardiac monitoring consolidates
High confidenceiRhythm's October 2026 VitalConnect acquisition was valued at $237.5 million in cash plus potential share issuance and is expected by iRhythm to enhance revenue growth beginning in 2027. The deal combines ambulatory cardiac monitoring with inpatient and hospital-to-home capabilities.[30][29]
Forecast 2027: Further consolidation is likely in 2027 as cardiac-monitoring companies seek scale in device manufacturing, algorithm development, reimbursement access and health-system sales. Competitive advantage will increasingly come from integrated clinical services rather than hardware alone.
08Diabetes remains a core application
High confidenceGrand View Research identifies diabetes as the largest application segment in the global RPM system market, with a 13.7% share in 2025. Connected glucose monitoring, chronic-care coaching and medication management make diabetes one of the most established recurring RPM workflows.[5]
Forecast 2027: In 2027, diabetes RPM will expand through tighter integration of continuous glucose data, medication support and virtual coaching. Competition will shift toward improving adherence and measurable glycemic outcomes rather than simply supplying glucose readings.
09Asia-Pacific grows faster than incumbents
High confidenceGrand View Research identifies North America as the largest regional market, with a 40.4% revenue share in 2025, while Asia-Pacific is forecast to have the fastest growth during the forecast period. This indicates a continuing transition from North American scale leadership to broader international adoption.[5]
Forecast 2027: In 2027, Asia-Pacific should outpace North America in percentage growth as hospitals, insurers and technology suppliers expand connected-care infrastructure. Market development will remain uneven, with reimbursement, broadband access and local device regulation determining country-level adoption.
10Medicare oversight tightens reimbursement
High confidenceCMS's 2027 physician-fee-schedule policy changes refine RPM and RTM requirements, including an initiating visit and tighter rules around who may furnish monitoring services. The final 2027 rule also delays the restriction on third-party monitoring arrangements until 2029, giving vendors and practices additional transition time.[14][15]
Forecast 2027: RPM providers will invest in stronger documentation, patient eligibility checks, clinical supervision and audit controls in 2027. Reimbursement growth should continue, but low-engagement or weakly integrated programs will face greater payment and compliance risk.
04 Statistics
Technology & AI
AI adoption signals remain uneven, with 16% reporting AI already implemented for clinical decision support in remote patient monitoring and 35% unsure within the next 18 months.
AI and automation in the remote patient monitoring industry
- 45% of 326 U.S. telehealth survey respondents said their organizations were already using or planned to use AI-enhanced telehealth technologies within the next 18 months, a parent-category proxy that includes remote patient monitoring.[1]
- 16% of surveyed healthcare leaders reported AI already implemented for clinical decision support in remote patient monitoring; the survey covered nearly 3,000 healthcare leaders across 14 countries in 2024.[2]
- 35% of 326 U.S. telehealth survey respondents were unsure whether their organizations would use AI-enhanced telehealth technologies within the next 18 months, a parent-category proxy that includes remote patient monitoring.[1]
Tools, systems and equipment in the remote patient monitoring industry
- 20.3% of U.S. physicians reported that remote patient monitoring was used in their practice in 2024, indicating adoption of RPM systems among the provider organizations delivering or operating the service.[3]
- 41% of 326 U.S. telehealth survey respondents identified remote patient monitoring kits or devices as a technology of interest; the survey is a parent-category proxy containing remote patient monitoring providers.[1]
- 37% of 326 U.S. telehealth survey respondents identified a remote patient monitoring solution as a software, service or system of interest for the following 18 months.[1]
05 Statistics
Market Intelligence
Market totals vary by scope: the RPM system market is $30.9B in 2026, while a separate software-and-services estimate was $8.47B in 2023.
Market size and service revenue in the remote patient monitoring industry
- $18.50 billion was the global remote patient monitoring market size in 2025, covering RPM devices, software and recurring monitoring services rather than services alone.[4]
- $26.0 billion was the global remote patient monitoring system market size in 2025, covering remote monitoring systems and associated connected-device categories.[5]
Regional breakdown of the remote patient monitoring industry
- Europe’s remote patient monitoring market was valued at $17.84 billion in 2025.[6]
- North America accounted for 40.4% of global remote patient monitoring system market revenue in 2025.[5]
- The United States represented $889.9 million of the global remote patient monitoring market in 2025, according to Acuitas Health Analytics’ country estimates.[7]
06 Statistics
Strategy & Growth
Deal flow shows consolidation in cardiac RPM, including iRhythm’s $237.5 million acquisition of VitalConnect in October 2026.
M&A and consolidation in the remote patient monitoring industry
- $478.3 million was the total disclosed value of six global remote patient monitoring-related medical-device deals in Q3 2024.[8]
- 6 remote patient monitoring-related medical-device deals were announced globally in Q3 2024, according to GlobalData’s themed M&A classification.[8]
- $237.5 million in cash was paid for VitalConnect in iRhythm’s 2026 acquisition of the cardiac remote patient monitoring company.[9]
07 Statistics
Operating Benchmarks
Clinical support is broad in large U.S. systems, with 90% of physicians and 91% of nurses supporting remote patient monitoring in a spring 2025 survey.
Operating metrics used in the remote patient monitoring industry
- 90% of physicians and 91% of nurses supported remote patient monitoring in a spring 2025 survey of 39 senior clinical executives from large U.S. health systems.[10]
- 7% of 420 global biopharma and MedTech organizations had commercialized or rolled out remote patient monitoring in March 2024.[11]
- 46% of 39 senior clinical executives at U.S. health systems with more than $1 billion in operating revenue had implemented remote patient monitoring by spring 2025.[10]
08 Statistics
Pricing
Medicare RPM reimbursement is component-based, with one-time device setup and patient education at $19.73 under CPT 99453 and $43.02 every 30 days under CPT 99454.
Fees and price levels in the remote patient monitoring industry
- Average reimbursement per enrolled patient increased from $96.30 in Phase 1 to $124.17 in Phase 2 for a pharmacist-led hypertension RPM service in a U.S. primary-care practice.[12]
- $19.73 was the one-time 2025 Medicare fee for remote physiologic monitoring device setup and patient education under CPT 99453 in the United States.[13]
- Average charges per enrolled patient increased from $301.46 in Phase 1 to $412.93 in Phase 2 for a pharmacist-led hypertension RPM service in a U.S. primary-care practice.[12]
- $43.02 was the 2025 Medicare fee every 30 days for supplying an RPM device and collecting data under CPT 99454, subject to at least 16 readings, in the United States.[13]
09 Statistics
Risk & Compliance
CMS eligibility hinges on transmission frequency, requiring at least 2 physiologic readings every 30 days, and treatment management requires at least 30 minutes of clinical staff time per 30 days.
Regulation and licensing in the remote patient monitoring industry
- January 1, 2027 is the effective date for a CMS policy clarification that continuing remote monitoring beneficiaries do not need an initiating visit if other requirements are met, in the United States.[14]
- At least 30 minutes of clinical staff time per 30 days is required for CPT code 99458 remote physiologic monitoring treatment management in the United States, under the CY 2025 Physician Fee Schedule.[14]
- At least 2 physiologic readings must be collected and transmitted every 30 days for Medicare-covered remote patient monitoring in the United States, under CMS RPM eligibility guidance.[15]
Key questions about the Remote Patient Monitoring Industry
What is the 2026 market size for remote patient monitoring systems?
How fast is the remote patient monitoring system market growing from 2026 to 2033?
Which companies lead the remote patient monitoring industry?
What technology shift is showing up in remote patient monitoring adoption of AI?
How is the market structured between hospital software and system revenue in 2025?
What are the key Medicare RPM eligibility and labor requirements?
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Kevin O'Brien. (2026, February 13). Remote Patient Monitoring Industry Statistics. Gitnux. https://gitnux.org/remote-patient-monitoring-industry-statistics
Kevin O'Brien. "Remote Patient Monitoring Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/remote-patient-monitoring-industry-statistics.
Kevin O'Brien. 2026. "Remote Patient Monitoring Industry Statistics." Gitnux. https://gitnux.org/remote-patient-monitoring-industry-statistics.
Sources & references
30 sources cited across this report
telehealthresourcecenter.org
businesswire.com
ama-assn.org
- clarivanthealth.com
grandviewresearch.com
nextmsc.com
- acuitashealthanalytics.com
medicaldevice-network.com
fiercehealthcare.com
hmacademy.com
capgemini.com
pmc.ncbi.nlm.nih.gov
- connectwithcare.org
govinfo.gov
cms.gov
mordorintelligence.com
news.medtronic.com
telehealth.hhs.gov
techtarget.com
docs.publicnow.com
hhs.gov
smartmeterrpm.com
- thehealthtechsignal.com
thebusinessresearchcompany.com
investor.resmed.com
emergenresearch.com
en.wikipedia.org
cadence.care
investors.irhythmtech.com
sec.gov
